We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 46.89%
This Fund
S&P 500
This Quarter Est. Return
-5.32%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$5.08B
AUM Growth
-$638M
Cap. Flow
-$133M
Cap. Flow %
-2.61%
Top 10 Hldgs %
62.65%
Holding
54
New
9
Increased
13
Reduced
20
Closed
6

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$467M
2
CNC icon
Centene
CNC
+$104M
3
GPN icon
Global Payments
GPN
+$80.4M
4
WCC
WESCO International
WCC
+$65M
5
CAR icon
Avis
CAR
+$39.1M

Top Sells

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$200M
2
UHS icon
Universal Health Services
UHS
+$154M
3
FISV
Fiserv Inc
FISV
+$113M
4
CTVA icon
Corteva
CTVA
+$94.4M
5
DXC icon
DXC Technology
DXC
+$76.6M

Sector Composition

Rank Sector Weight
1 Healthcare 51.66%
2 Technology 14.48%
3 Industrials 10.25%
4 Materials 8.76%
5 Miscellaneous 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBUS icon
51
Cibus
CBUS
$126M
– –
-116,465
Closed -$2.62M
LBTYA icon
52
Liberty Global Class A
LBTYA
$3.64B
– –
-176,110
Closed -$2.98M
META icon
53
Meta Platforms (Facebook)
META
$1.47T
– –
-109,289
Closed -$53.1M
W icon
54
Wayfair
W
$14.2B
– –
-219,706
Closed -$14.9M
1 2
3

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Glenview Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Glenview Capital Management held 54 positions worth $5.08B, down 11% from $5.72B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Glenview Capital Management's Q2 2024 filing shows 9 new, 13 increased, 20 reduced and 6 closed positions. Its largest new stake was Centene: 1,431,312 shares worth $94.9M. The largest sale was Tenet Healthcare, an estimated $200M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 43% a quarter earlier, followed by Technology and Industrials.

  • Glenview Capital Management's largest Q2 2024 buy was Centene: 1,431,312 shares worth $94.9M.
  • Glenview Capital Management added most to CVS Health in Q2 2024, an estimated $467M increase.
  • Glenview Capital Management's biggest Q2 2024 reduction was Tenet Healthcare, cutting an estimated $200M.
  • Glenview Capital Management fully exited Meta Platforms (Facebook) in Q2 2024, selling an estimated $53.1M.
  • Glenview Capital Management's ten largest holdings make up 63% of its $5.08B portfolio in Q2 2024.
  • Glenview Capital Management opened 9 new positions and closed 6 in Q2 2024.
  • Glenview Capital Management's portfolio value fell 11% quarter-over-quarter to $5.08B.

Based on Glenview Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.